CIBC Private Wealth Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$819M Buy
762,246
+208,879
+38% +$200M 1.38% 11
2025
Q3
$422M Sell
553,367
-39,982
-7% -$29.8M 0.72% 29
2025
Q2
$463M Buy
593,349
+10,893
+2% +$8.46M 0.83% 22
2025
Q1
$423M Sell
582,456
-46,277
-7% -$38.5M 0.89% 21
2024
Q4
$495M Sell
628,733
-114
-0% -$94.4K 0.9% 18
2024
Q3
$557M Sell
628,847
-124,227
-16% -$112M 1% 15
2024
Q2
$691M Sell
753,074
-47
-0% -$37.6K 1.3% 11
2024
Q1
$573M Buy
753,121
+1,845
+0.2% +$1.31M 1.12% 14
2023
Q4
$438M Sell
751,276
-147
-0% -$85.8K 0.93% 22
2023
Q3
$404M Sell
751,423
-69,228
-8% -$35.7M 0.96% 21
2023
Q2
$385M Buy
820,651
+44,392
+6% +$18.6M 0.84% 26
2023
Q1
$285M Sell
776,259
-62,403
-7% -$21M 0.63% 40
2022
Q4
$52.4M Buy
838,662
+7,688
+0.9% +$2.73M 0.18% 98
2022
Q3
$269M Buy
830,974
+106,610
+15% +$33.8M 0.72% 38
2022
Q2
$235M Buy
724,364
+21,704
+3% +$6.51M 0.61% 51
2022
Q1
$201M Buy
702,660
+604,720
+617% +$156M 0.44% 66
2021
Q4
$27.1M Buy
97,940
+1,718
+2% +$436K 0.06% 223
2021
Q3
$22.2M Buy
96,222
+921
+1% +$227K 0.05% 234
2021
Q2
$21.9M Sell
95,301
-6,666
-7% -$1.34M 0.05% 239
2021
Q1
$19M Buy
101,967
+15,628
+18% +$3.06M 0.05% 254
2020
Q4
$14.6M Buy
86,339
+1,717
+2% +$256K 0.04% 282
2020
Q3
$12.5M Buy
84,622
+30,271
+56% +$4.68M 0.04% 264
2020
Q2
$8.92M Sell
54,351
-22,605
-29% -$3.47M 0.04% 244
2020
Q1
$10.7M Buy
76,956
+333
+0.4% +$45.8K 0.05% 242
2019
Q4
$10.1M Sell
76,623
-6,062
-7% -$703K 0.03% 284
2019
Q3
$9.25M Sell
82,685
-13,510
-14% -$1.5M 0.03% 287
2019
Q2
$10.7M Sell
96,195
-13,557
-12% -$1.6M 0.04% 276
2019
Q1
$14.2M Sell
109,752
-12,093
-10% -$1.47M 0.05% 246
2018
Q4
$14.1M Sell
121,845
-1,421
-1% -$159K 0.06% 227
2018
Q3
$13.2M Sell
123,266
-16,510
-12% -$1.65M 0.05% 265
2018
Q2
$11.9M Sell
139,776
-17,822
-11% -$1.46M 0.05% 270
2018
Q1
$12.2M Sell
157,598
-37,040
-19% -$2.98M 0.05% 263
2017
Q4
$16.4M Sell
194,638
-20,613
-10% -$1.75M 0.07% 230
2017
Q3
$18.4M Sell
215,251
-12,019
-5% -$986K 0.08% 202
2017
Q2
$18.7M Sell
227,270
-10,575
-4% -$863K 0.12% 138
2017
Q1
$20M Sell
237,845
-23,828
-9% -$1.91M 0.13% 131
2016
Q4
$19.2M Sell
261,673
-11,606
-4% -$864K 0.13% 135
2016
Q3
$21.9M Sell
273,279
-8,319
-3% -$666K 0.15% 126
2016
Q2
$22.2M Sell
281,598
-6,462
-2% -$486K 0.16% 122
2016
Q1
$20.7M Sell
288,060
-5,739
-2% -$434K 0.16% 124
2015
Q4
$24.8M Buy
293,799
+4,004
+1% +$332K 0.19% 117
2015
Q3
$24.3M Sell
289,795
-55
-0% -$4.64K 0.2% 108
2015
Q2
$24.2M Buy
289,850
+2,032
+0.7% +$155K 0.18% 117
2015
Q1
$20.9M Buy
287,818
+5,466
+2% +$389K 0.15% 126
2014
Q4
$19.5M Sell
282,352
-361
-0.1% -$24.4K 0.15% 128
2014
Q3
$18.3M Sell
282,713
-1,100
-0.4% -$69.6K 0.14% 133
2014
Q2
$17.6M Sell
283,813
-34,296
-11% -$2.05M 0.14% 139
2014
Q1
$18.8M Buy
+318,109
New +$17.8M 0.16% 129

Other funds holding LLY

CIBC Private Wealth Group's LLY Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Eli Lilly (LLY) stake by 38% in Q4 2025, buying an estimated $200M and bringing the position to 762,246 shares worth $819M. The position accounts for 1.38% of the portfolio, ranked #11.

CIBC Private Wealth Group first reported a position in LLY in Q1 2014 and has held it in 48 quarters since. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • CIBC Private Wealth Group held 762,246 shares of Eli Lilly worth $819M as of Q4 2025.
  • CIBC Private Wealth Group bought 208,879 Eli Lilly shares in Q4 2025, an estimated $200M.
  • Eli Lilly made up 1.38% of CIBC Private Wealth Group's portfolio in Q4 2025, its #11 holding.
  • CIBC Private Wealth Group first reported a position in Eli Lilly in Q1 2014 and has held it in 48 quarters since.
  • 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.